Targeting breast cancer metastasis Journal Article


Authors: Jin, X.; Mu, P.
Article Title: Targeting breast cancer metastasis
Abstract: Metastasis is the leading cause of breast cancer-associated deaths. Despite the significant improvement in current therapies in extending patient life, 30-40% of patients may eventually suffer from distant relapse and succumb to the disease. Consequently, a deeper understanding of the metastasis biology is key to developing better treatment strategies and achieving long-lasting therapeutic efficacies against breast cancer. This review covers recent breakthroughs in the discovery of various metastatic traits that contribute to the metastasis cascade of breast cancer, which may provide novel avenues for therapeutic targeting. © the authors, publisher and licensee Libertas Academica Limited.
Keywords: signal transduction; protein expression; gene mutation; drug safety; treatment planning; bone metastasis; drug targeting; outcome assessment; metastasis; breast cancer; gene amplification; epidermal growth factor receptor 2; gene function; enzyme activation; carcinogenesis; cancer resistance; cancer hormone therapy; cancer genetics; stroma; targeted therapy; cancer classification; estrogen receptor; drug sensitivity; tumor microenvironment; clinical trial (topic); molecularly targeted therapy; epithelial mesenchymal transition; metastasis inhibition; tumor invasion; oncological parameters; intratumor heterogeneity; human; article; precision medicine; metastatic traits; estrogen receptor antagonist
Journal Title: Breast Cancer: Basic and Clinical Research
Volume: 9
Issue: Suppl. 1
ISSN: 1178-2234
Publisher: Sage Publications  
Date Published: 2015-01-01
Start Page: 23
End Page: 34
Language: English
DOI: 10.4137/bcbcr.s25460
PROVIDER: scopus
PMCID: PMC4559199
PUBMED: 26380552
DOI/URL:
Notes: Export Date: 2 October 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ping Mu
    8 Mu